安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
MC180295 ((rel)-MC180295) is a novel potent and selective CDK9 inhibitor with an IC50 of 5 nM and is at least 22-fold more selective for CDK9 over other CDKs.
MC180295 ((rel)-MC180295) is a novel potent and selective CDK9 inhibitor with an IC50 of 5 nM and is at least 22-fold more selective for CDK9 over other CDKs.
MC180295 has broad anti-cancer activity in vitro[1].
MC180295 shows promising anti-tumoral and immunosensitization activity[1].
[1] Zhang H, et al. Cell. 2018, 175(5):1244-1258.
动态评分
0.0